the aid library

Práctica basada en evidencia en salud mental de la infancia y la adolescencia

J. Hamilton; F. Çuhadaroğlu-Çetin IACAPAP (2018) C2

Introducción Capítulo A.6 Edición: Matías Irarrázaval & Andres Martin Traductores: Fernanda Prieto-Tagle & Jaume Morey

La pratique de la médecine fondée sur les preuves en santé mentale de l'enfant et de l'adolescent

J. Hamilton; F. Çuhadaroğlu-Çetin IACAPAP (2017) C2

Introduction Chapitre A.6 Edition en français Traduction : Cristina Constantin Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Evidence-based Practice in Child and Adolescent Mental Health

J. Hamilton; F. Çuhadaroğlu-Çetin IACAPAP (2012) C2

Introduction Chapter A.6

The public health implications of the Paris Agreement: a modelling study

Hamilton I., Kennard H., McGushin A. et al. (2021) C2

The Lancet Planetary Health, Vol.5 Issue 2, Feb. 1,2021. Nationally determined contributions (NDCs) serve to meet the goals of the Paris Agreement of staying “well below 2°C”, which could also yield substantial health co-benefits in the process. However, existing NDC commitments are inadequa ... more

Depression in children and adolescents

J. M. Rey; T. T. Bella-Awusah; J. Liu IACAPAP (2015) C2

Mood disorders Chapter E.1 2015 edition

Реализация комплексных программ по вопросам ВИЧ и ИППП с мужчинами, имеющими секс с мужчинами.

J. Bear; G. Ayala; J. Butler; et al. (Джеймса Баера; Джорджа Айалы; Дженнифер Батлер; et al.) Фонд Организации Объединенных Наций в области народонаселения; UNFPA (2015) C2

ПРактИЧеское РукоВодстВо для соВместных меРоПРИятИй.

Depresión en ninos y adolescentes

J. M. Rey; T. T. Bella-Awusah; J. Liu IACAPAP (2017) C2

Trastornos del ánimo Capítulo E.1 Traducción de la versión inglesa del 2015

Tuberculosis in HIV/AIDS Patients

Gjergji, M.; j. Bushati; A. Harxkhi, et al. MedGrave (2017) C2

J Epidemiol Infect Dis 1(1): 00003.n DOI: 10.15406/jeid.2017.01.00003 Published: September 14, 2017

G2 Substance Use Disorders: Cannabis Use and Misuse

Alan J Budney & Catherine Stanger IACAPAP (2015) C1

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

Schwalm, J.; McKee, M.; Huffman, M. et al. Circulation (2016) CC

Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the ... more

Prioritised research agenda for prevention and control of chronic respiratory diseases

Bousquet, J.; Kiley, J.; Bateman, E.D. European Respiratory Journal (ERJ) (2010) C_WHO

The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of the World Health Organization's (WHO) action plan on noncommunicable diseases (NCDs) from 2008 to 2013. It highlights the significant global impact of CRDs, including ... more

Developing the Resilience Framework for Nursing and Healthcare

Morse, J.M.; et al. (2021) CC

Global Qualitative Nursing Research March 31, 2021 Research Article Find in PubMed https://doi.org/10.1177/23333936211005475

Climate change and mental health: risks, impacts and priority actions

Katie Hayes, G. Blashki, J. Wiseman et al. International Journal of Mental Health Systems (2018) CC

This article provides an overview of the current and projected climate change risks and impacts to mental health and provides recommendations for priority actions to address the mental health consequences of climate change.

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Measuring Health and Disability - Manual for WHO Disability Assessment Schedule (WHODAS 2.0)

Üstün, T.B., Kostanjsek, N., Chatterji, S. & Rehm, J. WHO (2010) C_WHO

This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders. The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac ... more

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Chung, K. F.; Wenzel, S. E.; Brozek, J. L.; et al. (2022) CC2

The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr ... more

The contribution of religious entities to health in sub-Sahara Africa

Schmid B, Thomas E, Olivier J and Cochrane JR. African Religious Health Assets Programme (ARHAP) (2008) CC